Urgency over clinical trials and medtech laws leaves P&R transparency out in the cold
This article was originally published in Scrip
Executive Summary
The race is on to get three major pieces of draft laws through the EU legislative process before the European Parliament elections in May 2014, with feverish behind-the-scenes negotiations taking place to thrash out a number of controversial issues that have arisen, mostly, from amendments by the European Parliament's environment and public health (ENVI) committee.